MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

Search

10X Genomics Inc (Class A)

Closed

SectorHealthcare

7.37 -2.51

Overview

Share price change

24h

Current

Min

7.5

Max

7.66

Key metrics

By Trading Economics

Income

-13M

-49M

Sales

13M

165M

EPS

-0.136

Profit margin

-29.71

Employees

1,306

EBITDA

-14M

-38M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+109.45% upside

Dividends

By Dow Jones

Next Earnings

8 May 2025

Market Stats

By TradingEconomics

Market Cap

1B

Previous open

9.88

Previous close

7.37

News Sentiment

By Acuity

100%

0%

368 / 385 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

10X Genomics Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

19 Apr 2025, 01:45 UTC

Earnings

Preview -- Barron's

18 Apr 2025, 15:57 UTC

Major Market Movers

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

20 Apr 2025, 22:32 UTC

Top News

Stocks Poised for Lower Open -- Barrons.com

20 Apr 2025, 18:43 UTC

Top News

Chicago Fed's Goolsbee Has a Warning About Independence -- Barrons.com

20 Apr 2025, 18:00 UTC

Top News

Tesla, Alphabet, Verizon, Chipotle, IBM, Boeing, and Many More Stocks to Watch This Week -- Barrons.com

20 Apr 2025, 13:00 UTC

Top News

Airbus Promised a Green Aircraft. That Bet Is Now Unraveling. -- WSJ

20 Apr 2025, 06:00 UTC

Top News

Foreign Stocks Are Beating the U.S. Market. Here's How Much You Should Have in Your Portfolio. -- Barrons.com

20 Apr 2025, 03:00 UTC

Top News

Putin's War Economy Can't Escape Trump's Trade Blitz -- WSJ

20 Apr 2025, 02:00 UTC

Top News

Who Will Pay the Price for Trump's Economic Goals? -- WSJ

19 Apr 2025, 02:00 UTC

Top News

Tomatoes Become One of the First Everyday Casualties of Trade War -- WSJ

19 Apr 2025, 02:00 UTC

Top News

Beijing Stokes Patriotic Fervor and Blames U.S. for Trade War -- WSJ

18 Apr 2025, 20:42 UTC

Acquisitions, Mergers, Takeovers

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 Apr 2025, 20:32 UTC

Top News

Trump to Replace Acting IRS Commissioner -- 2nd Update

18 Apr 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18 Apr 2025, 19:52 UTC

Market Talk

Correction to Aluminum Fee Rising Slower Than Forecast Article

18 Apr 2025, 19:40 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18 Apr 2025, 19:40 UTC

Market Talk

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18 Apr 2025, 18:51 UTC

Earnings

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18 Apr 2025, 18:40 UTC

Acquisitions, Mergers, Takeovers

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 Apr 2025, 18:29 UTC

Market Talk

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18 Apr 2025, 18:21 UTC

Top News

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18 Apr 2025, 17:31 UTC

Top News

Trump to Replace Acting IRS Commissioner -- WSJ

18 Apr 2025, 17:24 UTC

Acquisitions, Mergers, Takeovers

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18 Apr 2025, 17:22 UTC

Acquisitions, Mergers, Takeovers

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18 Apr 2025, 16:00 UTC

Top News

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18 Apr 2025, 15:53 UTC

Top News
Acquisitions, Mergers, Takeovers

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18 Apr 2025, 15:46 UTC

Earnings

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18 Apr 2025, 15:10 UTC

Market Talk
Earnings

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18 Apr 2025, 14:46 UTC

Earnings

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18 Apr 2025, 14:24 UTC

Market Talk
Earnings

Netflix Still Has Room to Add Subscribers -- Market Talk

Peer Comparison

Price change

10X Genomics Inc (Class A) Forecast

Price Target

By TipRanks

109.45% upside

12 Months Forecast

Average 15.73 USD  109.45%

High 26 USD

Low 12 USD

Based on 12 Wall Street analysts offering 12 month price targets for10X Genomics Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

6

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

7.33 / 7.52Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

No Evidence

Sentiment

By Acuity

368 / 385 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.